News

Medical technology company Inspire Medical Systems (NYSE:INSP) announced better-than-expected revenue in Q1 CY2025, with ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $215.54, a high ...
Inspire Medical Systems ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it ...
Inspire Medical Systems, Inc.’s INSP share price has dipped by 6.50%, which has investors questioning if this is right time ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has ...
Approximately 30 million U.S. adults are believed to have sleep apnea, but only 6 million have been officially diagnosed. Ellen Tolbert is one of them. “About, I want to say, close to 15 years ago, I ...
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...
The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 23 cents per share.
Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on treating obstructive sleep apnea (OSA), presented its latest corporate overview on May 5, 2025, highlighting ...
(AP) — Inspire Medical Systems Inc. (INSP ... below this ad The maker of devices for treating obstructive sleep apnea posted revenue of $201.3 million in the period, which also beat Street ...
Inspire Medical (TASE:BLWV) Systems, Inc. (NYSE:INSP), a medical technology company focused on treating obstructive sleep apnea (OSA), presented its latest corporate overview on May 5, 2025, ...